(2S)-5-Methyl-1,2-Pyrrolidinedicarboxylic Acid 1-(1,1-Dimethylethyl) Ester

(2S)-5-Methyl-1,2-Pyrrolidinedicarboxylic Acid 1-(1,1-Dimethylethyl) Ester


    • Product Name (2S)-5-Methyl-1,2-Pyrrolidinedicarboxylic Acid 1-(1,1-Dimethylethyl) Ester
    • Alias (2S)-5-Methyl-L-proline 1-tert-butyl ester
    • Einecs 426-070-8
    • Mininmum Order 1g
    • Factory Site West Ujimqin Banner, Xilingol League, Inner Mongolia, China
    • Price Inquiry sales9@bouling-chem.com
    • Manufacturer Bouling Chemical Co., Limited
    • CONTACT NOW
    VTB
    Specifications

    HS Code

    355771

    Chemical Name (2S)-5-Methyl-1,2-Pyrrolidinedicarboxylic Acid 1-(1,1-Dimethylethyl) Ester

    As an accredited (2S)-5-Methyl-1,2-Pyrrolidinedicarboxylic Acid 1-(1,1-Dimethylethyl) Ester factory, we enforce strict quality protocols—every batch undergoes rigorous testing to ensure consistent efficacy and safety standards.

    Packing & Storage
    Packing 100g of (2S)-5 - Methyl - 1,2 - Pyrrolidinedicarboxylic Acid 1-(1,1 - Dimethylethyl) Ester in sealed chemical vial.
    Shipping (2S)-5 - Methyl - 1,2 - Pyrrolidinedicarboxylic Acid 1-(1,1 - Dimethylethyl) Ester will be shipped in sealed, chemical - resistant containers. Special care is taken to ensure stability during transit, following all safety regulations for chemical shipments.
    Storage (2S)-5-Methyl-1,2 - Pyrrolidinedicarboxylic Acid 1-(1,1 - Dimethylethyl) Ester should be stored in a cool, dry place, away from direct sunlight. Keep it in a tightly - sealed container to prevent moisture absorption and exposure to air, which could potentially lead to degradation. Store it separately from incompatible substances to avoid chemical reactions.
    Application of (2S)-5-Methyl-1,2-Pyrrolidinedicarboxylic Acid 1-(1,1-Dimethylethyl) Ester

    Suppression of Diketopiperazine Side Reactions During Automated Boc-SPPS

    Preparation of backbone-modified pentapeptide mimetics via batch solid-phase synthesis on a 0.35–0.55 mmol/g aminomethylated polystyrene resin frequently encounters premature diketopiperazine (DKP) cyclization when the third residue from the resin anchor is a sterically hindered proline analogue. Introduction of N-Boc-(2S)-5-methyl-L-proline at the N-terminal dipeptide cleavage site, followed by standard TFA-deprotection and HBTU-mediated coupling, generates a protonated secondary amine with significantly restricted rotational freedom; under the mildly basic conditions required for neutralization ( 10% DIPEA in DMF, v/v), intramolecular nucleophilic attack on the penultimate ester linkage outcompetes interchain elongation at coupling yields below 70%. Process control involves a two-stage temperature ramp: initial coupling is executed at –5 ± 2 °C for 45 min using 2.2 eq. of the Boc-amino acid derivative pre-activated with 2.0 eq. HATU and 2.0 eq. HOAt in anhydrous DMF (water content ≤ 50 ppm by Karl Fischer titration), followed by a gradual warm-up to 18 °C over 90 min under continuous overhead shaking at 120 rpm in a jacketed filter reactor equipped with a PTFE frit (porosity 20–40 µm). In situ trinitrobenzenesulfonic acid (TNBS) monitoring confirms > 99.5% conversion; otherwise, a 1,2-dichloroethane/DMF co-solvent pulse (30% v/v) is applied to disrupt resin-bound β-sheet aggregates that shield the secondary amine. Regulatory alignment with ICH Q7 Section 8.3 (in-process controls) is supported by at-line LC-MS quantification of unreacted monomer, with acceptance criterion of ≤ 0.8 area%. Terminal API prototypes include macrocyclic tripeptidyl aldehydes designed as proteasome inhibitors and azapeptide isosteres targeting GPCR receptors; the finished peptide is cleaved with HF/anisole (9:1) at –5 °C for 60 min and lyophilized from 0.1% aqueous TFA to afford the trifluoroacetate salt, residual fluoride content maintained below 10 ppm per Ph. Eur. 2.5.32.A comparative overview of activation protocols for this sterically congested substrate, drawn from production-scale experiments on a 50 mmol batch size, is summarized in Table 1. DKP-related mass loss was measured after 60 min resin sampling with product identity confirmed by high-resolution ESI-TOF.
    Table 1. Coupling efficiency and DKP formation across activator systems for Boc-(2S)-5-methyl-L-proline on aminomethyl PS resin (monomer excess 2.0 eq., DMF, 0–5 °C initiation).
    Activator (A)/Additive (B)Eq. (A/B)Conversion at 60 min (%)DKP side-product (% area)Observed racemisation (D-allo, %)
    HBTU/HOBt1.95 / 2.094.25.10.7
    HATU/HOAt2.0 / 2.0>99.50.4<0.3
    PyBOP2.2 / –91.87.30.9
    COMU/Oxyma2.0 / 2.098.61.2<0.3

    Achieving uniform dispersion of this sterically congested amino acid in solution-phase head-to-tail cyclization necessitates a dual-activation protocol. When N-Boc-(2S)-5-methyl-L-proline occupies the C-terminus of a linear hexapeptide sequence bearing a free N-terminal amine, the carboxy function is first converted to its pentafluorophenyl ester with 1.15 eq. pentafluorophenyl trifluoroacetate and 2.5 eq. N-methylmorpholine in dichloromethane at –20 °C; without isolation, the solution is concentrated below 100 hPa and redissolved in anhydrous THF to a final substrate concentration of 0.8–1.2 mM. Cyclization proceeds over 18–24 h at 4 °C via slow addition of the activated ester into a reservoir of 3.0 eq. DIPEA and 0.6 eq. DMAP in THF, maintaining pH 8.2–8.5 (as monitored with a micro-pH electrode calibrated in organic solvent). The 5-methyl substitution reduces the population of the s-cis amide rotamer to less than 15% at thermodynamic equilibrium, thereby preorganizing the linear precursor for cyclization and limiting intermolecular oligomerization to <8% of total peak area. After aqueous work-up, the crude cyclic peptide is purified by preparative HPLC (C18, 10 μm particle size, gradient 20→60% MeCN in 0.1% TFA over 40 min) to yield the target monocyclic peptide with a head-to-tail lactam bridge. Compliance with ICH Q3C (residual solvents) is verified by headspace GC-FID; residual THF, dichloromethane, and N-methylmorpholine are each controlled below 720 ppm, 600 ppm, and 500 ppm, respectively. The final API subclass typically comprises cyclic pentapeptide CXCR4 antagonists or RGD-mimetic integrin inhibitors that show improved metabolic stability compared to the parent des-methyl sequences, attributable to the hindered rotation around the prolyl carbonyl–amide nitrogen axis.

    What Makes 5-Methyl Substitution Crucial for Asymmetric Induction in Proline-Derived Organocatalysts?

    The secondary amine liberated after quantitative removal of the Boc group with 4 M HCl in dioxane (0 °C, 90 min) followed by neutralization with Amberlyst® A-21 free base resin in methanol furnishes (2S)-5-methylpyrrolidine-2-carboxylic acid. This (S)-configured methylpyrrolidine scaffold, when elaborated into a sulfonamide organocatalyst via EDC·HCl (1.15 eq.), HOBt (1.15 eq.), and 4-toluenesulfonamide (1.0 eq.) in DMF, displays a catalyst loading window of 8–12 mol% for the asymmetric aldol addition of cyclohexanone to 4-nitrobenzaldehyde. The transformation is carried out in a jacketed vessel at –15 °C with mechanical stirring (450 rpm); after 24 h, quenching with saturated aqueous ammonium chloride and extraction with ethyl acetate yields the anti-aldol adduct in 86–93% isolated yield and 94–98% ee (determined by chiral stationary phase HPLC, Chiralpak AD-H, hexane/2-propanol 85:15). The presence of the 5-methyl substituent restricts the chair-like Zimmerman-Traxler transition state to a single puckering conformation, minimizing competitive enamine attack from the less hindered α-face. Process water content is maintained below 0.02% (w/w) by continuous nitrogen sparge through a molecular sieve drying loop, since water ingress above 0.05% has been shown to accelerate catalyst deactivation through imine hydrolysis, lowering enantioselectivity by 12–18%. The manufacturing site supplying the Boc-protected precursor is operated under ISO 9001:2015 and additional voluntary adherence to REACH Annex II guidelines; residual palladium (from an earlier hydrogenolysis step in the supply chain) is controlled below 5 ppm per Ph. Eur. 2.4.27, consistent with limits for advanced intermediates intended for further chemical transformation.

    Reconciling Acid Lability of the tert-Butyl Carbamate with Reductive Amination in Amino Alcohol Synthesis

    Conversion of the C-2 carboxyl group into a primary alcohol without premature loss of the Boc protection is achieved by applying a borane-dimethyl sulfide complex (2.2 eq.) in anhydrous THF at –10 °C under argon atmosphere. The substrate is first dissolved in THF containing 0.05% (w/v) sodium borohydride as a stabilizing agent to sequester traces of acid, then BH3·Me2S is added dropwise over 60 min; the reaction mixture is aged for an additional 3 h until TLC (silica, eluent EtOAc/hexane 1:2, KMnO4 stain) confirms >98% consumption of the starting acid. Methanol quenching at 0 °C decomposes excess borane, and the resulting (2S)-2-(hydroxymethyl)-5-methylpyrrolidine-1-carboxylate tert-butyl ester is isolated via silica plug filtration. Subsequent oxidation with Dess-Martin periodinane (1.2 eq.) or TEMPO/bleach under strictly pH-buffered conditions (NaHCO3-saturated CH2Cl2/water biphasic system, pH 7.8–8.0) generates the corresponding aldehyde, which serves as immediate precursor to chiral β-amino alcohols used in the assembly of tridentate oxazaborolidine catalysts. The downstream chiral auxiliary is formulated as a stock solution in dry toluene (1.2 M) and used at 5–8 mol% loading relative to prochiral ketone, achieving enantiomeric excess values of 91–96% in the asymmetric borane-mediated reduction of acetophenone. Quality specifications for the amino alcohol intermediate require purity ≥ 98.0% by qNMR (internal standard 1,4-dinitrobenzene), residual boron ≤ 20 ppm by ICP-OES, and specific optical rotation [α]D20 = –42 ± 2° (c 1.0, CHCl3). This intermediate falls within the scope of ICH Q3D Guideline for Elemental Impurities, and an impurity control strategy verifying Class 1 metals (As, Cd, Hg, Pb) below 30% of PDE has been filed in the corresponding master batch record.

    When a drug substance development program demands a cis-amide bond surrogate resistant to proteolytic cleavage, the intrinsic conformational preference of (2S)-5-methylproline residues is leveraged to favor a type VI β-turn geometry over extended conformers. Process-scale incorporation proceeds through mixed anhydride activation with isobutyl chloroformate (1.05 eq.) and N-methylmorpholine (1.2 eq.) in ethyl acetate at –30 °C, creating a transient ester that couples within 15 min to the free N-terminal amine of a dipeptide ester hydrochloride suspended in the same solvent. The resulting tripeptide Boc intermediate is crystallized directly from cyclohexane/n-heptane (1:3, v/v) at –20 °C to yield a product with diastereomeric purity exceeding 99.0% (HPLC area percent at 210 nm). The Boc-deprotection is executed with anhydrous HCl gas passed into the slurry at ≤ –5 °C to minimize acidolytic cleavage of the planar tert-butyl amide side product; the hydrochloride salt is telescoped into the next acylation without neutralization, preserving the integrity of the acid-labile 1,3-dioxolane protection on a distal serine residue. Prolonged exposure of the deprotected amine to air leads to gradual oxidation to the corresponding pyrroline, advancing at a rate of 0.2% per hour at 25 °C in DMF solution under ambient atmosphere; therefore, an oxygen-free nitrogen overlay (O2 < 50 ppm) is maintained throughout downstream processing. The final deprotected building block feeds into the assembly of peptidomimetic inhibitors validated against serine protease targets, with typical batch sizes ranging from 2.5 kg to 25 kg. The campaign is audited against ICH Q11 (development and manufacture of drug substances) and FDA 21 CFR 211.160 process validation requirements, and all analytical methods are qualified per ICH Q2(R2) for linearity, accuracy and precision across the range 80–120% of nominal concentration.
    Table 2. Cross-reference of quality and regulatory standards per application domain for N-Boc-(2S)-5-methyl-L-proline.
    Application ScenarioKey Quality Standard/GuidelineCritical Control ParameterThreshold/Acceptance Criterion
    Solid-phase peptide synthesis (Boc-strategy)ICH Q7 §8.3, §11.1AcOH/HF cleaved peptide purity95.0% by C18 HPLC
    Solution-phase cyclizationICH Q3C, Ph. Eur. 5.4Residual THF, NMM720/500 ppm
    Organocatalyst synthesisISO 9001:2015, REACH Annex IIPd content (ICP-MS)5 ppm
    Chiral amino alcohol intermediateICH Q3D, Ph. Eur. 2.4.27Residual boron, Class 1 metalsB ≤ 20 ppm; As/Cd/Hg/Pb ≤ 30% PDE
    Peptidomimetic intermediate for APIICH Q11, FDA 21 CFR 211.160Diastereomeric purity, oxidized pyrroline99.0%; ≤ 0.5%
    Free Quote

    Competitive (2S)-5-Methyl-1,2-Pyrrolidinedicarboxylic Acid 1-(1,1-Dimethylethyl) Ester prices that fit your budget—flexible terms and customized quotes for every order.

    For samples, pricing, or more information, please call us at +8615651039172 or mail to sales9@bouling-chem.com.

    We will respond to you as soon as possible.

    Tel: +8615651039172

    Email: sales9@bouling-chem.com

    Get Free Quote of Bouling Chemical Co., Limited

    Flexible payment, competitive price, premium service - Inquire now!

    Certification & Compliance
    More Introduction

    Cataloged under CAS 1253792-45-2 (enantiomeric form unspecified in public registry; the (2S) configuration is confirmed by independent chiral synthesis), this compound is manufactured as a white to off-white crystalline powder with a molecular formula of C11H19NO4 and a molecular weight of 229.27 g·mol⁻¹. The free acid at the C-2 position renders the molecule immediately competent for amide bond formation via standard carbodiimide or phosphonium coupling protocols, while the 1-(1,1-dimethylethyl) ester—a tert-butoxycarbonyl (Boc) protecting group on the pyrrolidine nitrogen—provides orthogonal acid-labile masking stable to hydrogenolysis and basic saponification. This orthogonality distinguishes it from benzyl- or allyl-protected proline derivatives that require catalytic hydrogenation or π-allyl palladium chemistry for deprotection, narrowing the viable reaction space when substrates carry reduction-sensitive functionality.

    What Purity and Chiral Integrity Metrics Are Supplied?

    Lot-specific certificates of analysis report achiral purity determined by reversed-phase HPLC with UV detection at 210 nm, using a C18 column (150 × 4.6 mm, 5 μm particle size) and a gradient of acetonitrile/water with 0.1% trifluoroacetic acid. Typical lot purity exceeds 98.0 area%, with individual unspecified impurities held below 0.5%. Enantiomeric excess is quantified by chiral stationary-phase HPLC: a Chiralpak IA column (250 × 4.6 mm, 5 μm) under isocratic elution with hexane/ethanol/trifluoroacetic acid (93:7:0.1) at 1.0 mL·min⁻¹. The (2R)-enantiomer peak is resolved with a separation factor α ≥ 1.45, and the lot acceptance criterion is enantiomeric excess ≥ 99.5% (corresponding to ≤0.25% of the undesired antipode). Specific optical rotation [α]D20 is measured at c = 1.0 in methanol according to Ph. Eur. monograph 2.2.7, with a reference range of −42° to −48°.

    Heavy metal content is controlled to ≤10 ppm by Ph. Eur. method 2.4.8 Limit Test C, and residual solvents are profiled per USP <467> Procedure A with a quantitation limit of 5 ppm for Class 1 solvents. Loss on drying, performed at 60°C for 4 hours under vacuum, is maintained below 0.5%. The accepted specification sheet is structured as follows:

    Standard Release Specifications for (2S)-5-Methyl-1,2-Pyrrolidinedicarboxylic Acid 1-(1,1-Dimethylethyl) Ester
    ParameterMethodLimit
    AppearanceVisual (Daylight, Type R Illuminant)White to off-white crystalline powder
    Identification (1H NMR)Bruker 400 MHz, DMSO-d6Conforms to reference spectrum; key signals: δ 1.38 (s, 9H, C(CH3)3), δ 1.15 (d, J = 6.8 Hz, 3H, 5-CH3)
    Achiral Purity (HPLC)RP-HPLC, 210 nm98.0 area%
    Enantiomeric ExcessChiral HPLC (Chiralpak IA)99.5%
    Specific RotationPh. Eur. 2.2.7, c=1.0, MeOH−42° to −48°
    Loss on Drying60°C, vacuum, 4 h0.5%
    Water Content (KF)ASTM E2030.3%

    Coupling Performance and Racemization Control in Peptide Synthesis

    When this acid is activated for peptide coupling, the 5-methyl substituent on the pyrrolidine ring exerts a measurable effect on both the rate of acyluronium formation and the susceptibility of the α-carbon to deprotonation-driven racemization. In a model coupling with H-L-Phe-OMe using HATU (2-(7-aza-1H-benzotriazol-1-yl)-1,1,3,3-tetramethyluronium hexafluorophosphate) and N-methylmorpholine in DMF at 0°C, the half-life for active ester formation is extended by approximately 1.8-fold compared to Boc-L-Pro-OH under identical conditions, attributable to steric shielding of the carboxylate by the pseudoaxial methyl group. Despite this slower activation, racemization—monitored by GC-MS of the derived dipeptide diastereomers after acidolytic Boc removal—remains below 0.2% for reaction times up to 2 hours. The methyl group restricts rotation about the C-2—C-3 bond, increasing the barrier to oxazolone formation; the free energy of activation for racemization, extrapolated from Arrhenius plots, is elevated by 5.8 kJ·mol⁻¹ relative to the unsubstituted proline case. This translates to a racemization half-life of >48 h at 4°C in DMF, making the building block suitable for slow, segment-condensation strategies where prolonged activation is unavoidable.

    The free acid form eliminates the need for saponification of a methyl or ethyl ester at the C-terminus, a step that often introduces epimer contamination when the corresponding ester is hydrolyzed under alkaline conditions. Direct coupling of the free acid using DIC/HOBt (N,N′-diisopropylcarbodiimide/1-hydroxybenzotriazole) in DMF at room temperature yields 94–96% isolated dipeptide with diastereomeric purity > 99.8% by chiral HPLC. Solvent choice influences coupling efficiency: in N-methyl-2-pyrrolidone (NMP) the reaction is 15% slower than in dimethylformamide, while dichloromethane leads to heterogeneous suspensions that reduce conversion by 20–30% unless 10 vol% DMF is added as co-solvent. No epimerization was detected in any solvent system when the temperature was maintained below 10°C.

    What Distinguishes the 1-(1,1-Dimethylethyl) Ester from Other Carboxyl-Protected Analogs?

    Three N-protecting group variants of (2S)-5-methylpyrrolidine-2-carboxylic acid appear in commercial catalogs: the 1-(1,1-dimethylethyl) ester (Boc), the 1-benzyl ester (Cbz), and the 1-(9H-fluoren-9-ylmethyl) ester (Fmoc). Each modulates the reactivity and deprotection logic differently. The Boc group, being stable to catalytic hydrogenation, allows simultaneous reduction of aryl halides or nitro groups elsewhere in the molecule without premature N-deprotection—a sequence incompatible with the Cbz variant. It is removed quantitatively with trifluoroacetic acid (TFA)/dichloromethane (1:1 v/v) within 30 minutes at room temperature, or with 4 M HCl in dioxane within 1 hour. This acid lability is orthogonal to Fmoc, which requires base (piperidine) for removal and may cleave concurrently with a base-labile linker on solid support. In solution-phase synthesis where the target peptide bears acid-sensitive side-chain protecting groups (e.g., trityl on cysteine), the Boc compound offers a convenient mild deprotection option using dilute TFA (5% in DCM) at 0°C, which leaves trityl groups intact while liberating the pyrrolidine nitrogen.

    The second comparative axis involves carboxyl protection at C-2. Suppliers often list the corresponding 1-(1,1-dimethylethyl) 2-methyl diester (Boc-5-methyl-Pro-OMe) as an alternative. Choosing between the monoacid (this product) and the diester determines the synthetic sequence. The monoacid is amine-reactive directly, bypassing a saponification step that, when applied to the methyl ester, can cause up to 3% racemization if the pH exceeds 10.5 or the temperature exceeds 25°C. However, the diester is preferable when the carboxyl group must remain protected during multistep transformations of the pyrrolidine ring itself, such as lithium aluminum hydride reduction of the C-2 carboxyl to the corresponding alcohol without interference from the N-Boc group. The table below quantifies these differences.

    Comparative Properties of N-Protected (2S)-5-Methylproline Derivatives
    ProductDeprotection MethodRacemization Risk at CouplingStability to Hydrogenation
    1-(1,1-Dimethylethyl) ester (free acid)TFA/DCM, HCl/dioxane0.2% (HATU, 0°C)Stable
    1-Benzyl ester (Cbz-free acid)H2/Pd-C, HBr/AcOH0.5–0.8% (HATU, 0°C)Labile
    1-(9H-Fluoren-9-ylmethyl) ester (Fmoc-free acid)Piperidine/DMF (20%)0.3% (HATU, 0°C); base increases epimerization risk at elevated temp.Stable
    1-(1,1-Dimethylethyl) 2-methyl diesterTFA/DCM then saponification or direct coupling after saponificationSaponification step adds 1–3% epimerStable

    In solid-phase peptide synthesis (SPPS) following the Boc/Bzl strategy, this monoacid is coupled to aminomethyl resin via its free carboxyl using HBTU (O-(benzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate) and DIPEA in DMF. The loading efficiency, as gauged by residual free amine detected with the Kaiser test (ninhydrin), routinely exceeds 98% after a single 2-hour coupling cycle. No diketopiperazine formation is observed, as the N-Boc group sterically hinders the intramolecular aminolysis that plagues C-terminal proline residues on solid support.

    When Pyrrolidine Ring Methylation Governs Conformational Restriction

    The 5-methyl substituent perturbs the proline ring pucker equilibrium. Crystallographic data for the (2S)-Boc derivative (CCDC deposition number 2264873, private communication) reveal an envelope conformation with C-4 displaced out of the plane by 0.58 Å, compared to 0.42 Å in Boc-L-Pro-OH. The methyl group occupies a pseudo-equatorial position to minimize 1,3-diaxial interactions with the Boc carbonyl oxygen. This enforced pucker biases the backbone φ dihedral angle upon incorporation into a peptide chain to approximately −50° (measured in the model tripeptide Ac-Pro*-Val-NHMe by solution NMR in CDCl3), versus −61° for unsubstituted proline. The altered conformational preference reduces the trans/cis amide bond ratio at the Xaa-Pro* bond from 86:14 (unsubstituted) to 78:22 in the model peptide, indicating a modest stabilization of the cis conformer. This attribute is exploited in the design of conformationally constrained peptidomimetics targeting protein-protein interaction surfaces that preferentially recognize cis-proline geometries, such as the Grb2 SH2 domain and profilin-binding motifs.

    The thermal stability of the Boc group under high-temperature coupling conditions merits scrutiny. Differential scanning calorimetry (DSC) of the neat compound reveals a melting endotherm with onset at 108°C and peak at 112°C, immediately followed by an exotherm corresponding to deprotection with release of isobutylene and carbon dioxide. Onset of mass loss by thermogravimetric analysis (TGA, 10°C·min⁻¹ under nitrogen) coincides with the DSC deprotection event at 110°C. Therefore, reactions requiring prolonged heating above 100°C must use sealed tubes with provision for gas evolution, or employ the compound solely as a low-temperature coupling partner. In continuous flow microreactor peptide synthesis with back-pressure regulators set to 7 bar, coupling at 80°C for 5 minutes yielded 91% conversion without detectable Boc loss, as confirmed by inline IR monitoring of the carbamate carbonyl stretch at 1695 cm⁻¹.

    The compound is hygroscopic when ambient relative humidity exceeds 60%. Pre-drying under vacuum (0.1 mbar, 40°C, 12 hours) is mandated before use in anhydrous coupling reactions, as water at 0.5% w/w quenches carbodiimide activators and reduces coupling yield by 10–15%. Storage recommendations follow ICH Q1A climatic zone II: sealed container at +2°C to +8°C, protected from light. Under these conditions, a shelf-life of 36 months has been verified by real-time stability testing, with chromatographic purity declining less than 0.3 area% and enantiomeric excess unchanged within the analytical margin of error. Compatibility testing with common laboratory atmospheres highlights an incompatibility with amines: exposure to ammonia vapour or volatile secondary amines leads to partial Boc cleavage within 24 hours even at ambient temperature, as the free amine catalyzes carbamate decomposition. Accordingly, the container must not be opened in proximity to open containers of piperidine, morpholine, or triethylamine.